Kate Lewis – President, BIOLIFE4D
Kate Lewis is the President and a major shareholder of BIOLIFE4D, a pioneering biotech company laser focused on leveraging advances in life sciences and tissue engineering that gives patients and their families the gift of time. Lewis was appointed President in September 2020, after joining BIOLIFE4D in 2019 to lead the Market and Business Development efforts. Applying her commercialization expertise, she has been developing BIOLIFE4D’s message, identifying critical stakeholders, building strategic partnerships, and expanding marketplace position.
Lewis is a seasoned, strategic business executive, with over 25 years of experience, working alongside global leaders within the pharmaceutical, transplantation and regulatory industries. Accomplished in her field, she has served as an active Board member on the American Lung Association and has been a GlaxoSmithKline (“GSK”) President’s Club Award winner for many years. The strength of her relationships in the pharmaceutical and medical communities and her gift of communicating complex issues and technologies to the public is part of what Lewis brings to BIOLIFE4D.
Lewis is dedicated to the mission of perfecting the technology to make viable organ replacement a safe, accessible, and affordable reality. As President, Lewis champions BIOLIFE4D’s message to individuals who could benefit most; patients with heart conditions, healthcare professionals treating individuals with cardiac issues, and pharmaceutical companies developing new therapies/treatments which require cardiotoxicity testing, as part of their FDA approval process.
Prior to BIOLIFE4D, Lewis was Founder of Nottingham Associates, a consulting firm focused on strategic client solutions for Pharma. Her work included refining market development initiatives and building Key Opinion Leader (KOL) boards within the pharmaceutical industry, clinical research, medical associations, and advocacy organizations. Another significant accomplishment was assisting to increase market share of the number one treatment of asthma globally and contributing to the improvement in quality-of-life for countless individuals suffering from asthma. Additionally, through a collaboration with Harvard University and GSK, Lewis helped design a groundbreaking study – “Asthma in America” – which helped identify 4.3 million individuals with previously undiagnosed asthma.
Lewis received her Bachelor’s in Fine Arts and Business from Ball State University and San Diego State University, respectively. She has earned certificates from Harvard University Executive Leadership Programs and as a National Asthma Educator. She has been trained in Tony Robbins Business Mastery, Stephen Covey’s Leadership, Myers-Briggs Type Indicator (MBTI), and in Fine Arts Mastery from the Cleveland Foundation. She also actively participates in National Association for Female Executives and Women in BIO.
Lewis has come full circle in her mission to advance the health and wellness of others. Having lost her husband to a heart attack and her father to lung disease as a child, she has dedicated her professional career to education and advancing therapies which improve the quality-of-life for others. Kate’s other passions include being involved in community, philanthropic and humanitarian activities. These include being a founder and serving on the Board of Home of the Sparrow for abused and battered women and spearheading medical relief efforts and humanitarian aid for both Hurricane Irma and Maria survivors in the Caribbean. Kate also enjoys spending time with her two Sons and extended Family.
Kate Lewis can be reached by email at klewis@biolife4d.com.
